Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The VETERANS AFFAIRS, DEPARTMENT OF has issued a Tender notice for the procurement of a Pharmarcokinetics for Experimental Rheumatoid Arthritis Treatment in the USA. This Tender notice was published on 21 Jul 2026 and is scheduled to close on 31 Jul 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 145573616, while the tender notice number is 36C24526Q0669 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Pharmarcokinetics for Experimental Rheumatoid Arthritis Treatment
Deadline: 31 Jul 2026
Posting Date: 21 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145573616
Document Ref. No.: 36C24526Q0669
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
PRE SOLICITATION NOTICE
Department of Veterans Affairs Network Contracting Office (NCO) 05
Title: A Joint Targeted Drug Delivery Approach for Arthritis Therapy Toxicity and Pharmacokinetics
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 05, intends to issue a solicitation for preclinical toxicology and pharmacokinetic (PK) studies to support advancement of an experimental joint targeted liposomal delivery system for Rheumatoid Arthritis therapy. This requirement involves GLP compliant toxicity studies and GLP or non GLP PK studies in adult rats.
The forthcoming solicitation will seek a contractor capable of performing:
GLP single dose IV toxicity studies including clinical observations, weight/food intake monitoring, blood chemistry assessments, necropsy, and histopathology.
GLP or non GLP pharmacokinetic studies including IV dosing, timed blood collection, plasma processing and storage, LC MS/MS analysis of dexamethasone and 6 hydroxydexamethasone, and calculation of PK parameters.
A comprehensive final written report covering toxicity results, PK data, and analytical findings.
Place of performance will be the contractor s laboratory. The anticipated period of performance is one year, approximately September 15, 2026 through September 14, 2027.
This notice is issued solely for informational purposes. A formal solicitation and the Government s acquisition strategy will be issued after completion of market research.
This notice does not constitute a solicitation and does not commit the Government to award a contract.
Point of Contact:
Robert O Keefe Jr., Contract Specialist
Email: [email protected]
Notice ID: 36c24526q0669
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: 245-network contract office 5 (36c245)
Product Service Code: aj13 - general science & technology r&d svcs; general science & technology; experimental development
NAICS Code: 112990 - All Other Animal Production
Inactive Dates: sep 29, 2026
Inactive Policy: manual
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google